Interleukin-1 receptor-associated kinase 1 messenger RNA 3' untranslated region (IRAK1 mRNA 3'-UTR) (IRAK1 mRNA 3'-UTR)

The Interleukin-1 receptor-associated kinase 1 (IRAK1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment that controls the expression of the IRAK1 protein, a key mediator in the Toll-like receptor (TLR) and Interleukin-1 receptor (IL-1R) signaling pathways (Taganov et al., 2006, Nature Immunology). This region contains specific binding sites for microRNAs, most notably miR-146a, which functions as a negative feedback regulator to prevent excessive inflammatory responses by inducing mRNA degradation or translational repression (Boldin et al., 2011, Journal of Experimental Medicine). In various pathological states, such as myelodysplastic syndromes and certain solid tumors, the regulatory control exerted through the 3'-UTR is often lost or bypassed, leading to IRAK1 protein overexpression and constitutive activation of the NF-kappaB pathway (Starczynowski et al., 2010, Nature Medicine). Therapeutic strategies targeting this mRNA region involve the use of microRNA mimics or antisense oligonucleotides designed to restore normal regulation or silence IRAK1 expression (Saba et al., 2014, Blood). By modulating the stability and translation of IRAK1 mRNA, these interventions aim to dampen chronic inflammation and inhibit the progression of IRAK1-dependent malignancies. Consequently, the IRAK1 mRNA 3'-UTR represents a strategic target for precision RNA-based therapies in immunology and oncology.

Other names

IRAK1 3'-UTRIRAK-1 3'-UTRInterleukin-1 receptor-associated kinase 1 3'-untranslated regionIRAK1 mRNA regulatory region

Post-transcriptional gene silencing via microRNA-mediated mRNA degradation or translational inhibition.